Clinical Trial Update: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating degarelix in controlled ovarian hyperstimulation for women with polycystic ovary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Ovarian Hyperstimulation Syndrome
• Polycystic Ovary Syndrome

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy | Conditions: PCOS, OHSS | Phase 3 | Status: COMPLETED